Delta Variant: The New Challenge of COVID-19 Pandemic, an Overview of Epidemiological, Clinical, and Immune Characteristics.

Acta Biomed · 2022 · PMC8972886 · PMID 35315394

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

quite significantno p-value reported

Immunogenicity in people under 40 years of age was quite significant in 98% of people, and in over 60 years, the success rate was high in 93% of people ( 66 ).

also in 5,695 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.